Login

Ownership

13F as of Q2 2026 · 53.2M shares outstanding

Who owns KalVista Pharmaceuticals, Inc.?

By type of holder
Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 10 holders own 11.6%
Frazier Life Sciences Public Fund, L.P. 2.4% · Fhmlsp, L.P. 2.4%
Institutional ownership
0.0%
-100.0 pts vs last qtr
Institutional holders
1
-183 vs last qtr
Net shares bought
−69.3M
by institutions in Q2 2026
New / sold out
1 / 184
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • IFP Advisors, Inc NEW +7
Biggest sellers in Q2 2026
  • Venrock Adviser, LLC SOLD OUT −6.5M
  • Frazier Life Sciences Management, L.P. SOLD OUT −5.0M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$905K
1 notice from 1 person
Shares covered
33.8K
0.06% of the company
Arranged in advance
0%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$452.6K$905.2KDecJanFebMarAprMay 2026: $905.2K without a planMayJunJulAugSepOctNov
Largest proposed sellers
  • Christopher M Yea Officer $905K
Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025
+179.8%
+22.84% a year
Each share's claim on the business
−64.3%
shrank without buying or selling a share
Diluted shares, split-adjusted
17.2M33.7M50.1M2020: 17.7M shares'202021: 19.1M shares'212022: 24.5M shares'222023: 27.9M shares'232024: 36.8M shares'242025: 49.7M shares'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%
Quarterly turnover
50.0%
of institutional shares changed hands
Top 10 managers, median time held
0 quarters

Super Investors

Investment managers reporting KalVista Pharmaceuticals, Inc. on Form 13F
VA
Venrock Adviser, LLC
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—
FL
Frazier Life Sciences Management, L.P.
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—

4 more super investors behind a free account

See every manager holding KalVista Pharmaceuticals, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting KalVista Pharmaceuticals, Inc. on Form N-PORT; together they hold 50.1% of the company
SW
SMALLCAP World Fund Inc
Position value
$56.5M
% of company
5.28%
% of the fund
0.07%
As of
March 31, 2026
VT
Position value
$27.2M
% of company
2.54%
% of the fund
0.00%
As of
March 31, 2026

23 more funds behind a free account

See every fund holding KalVista Pharmaceuticals, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
FL
Frazier Life Sciences Public Fund, L.P.
5%+ holder13D · 2.3%
Shares
1.2M
% of company
2.35%
Change vs last qtr
—
Held since
—
FL
Fhmlsp, L.P.
5%+ holder13D · 2.3%
Shares
1.2M
% of company
2.35%
Change vs last qtr
—
Held since
—

12 more holders behind a free account

See every insider and 5%+ holder of KalVista Pharmaceuticals, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support